Publication:
Diagnostic accuracy of Panbio™ rapid antigen test for SARS-CoV-2 in paediatric population

dc.contributor.authorGallardo-Alfaro, Laura
dc.contributor.authorLorente Montalvo, Patricia
dc.contributor.authorCañellas, Margarita A
dc.contributor.authorCarandell Jöger, Eugenia
dc.contributor.authorOliver, Antonio
dc.contributor.authorRojo Molinero, Estrella
dc.contributor.authorRiera, Beatriz
dc.contributor.authorLlobera Cánaves, Joan
dc.contributor.authorBulilete, Oana
dc.contributor.authorLeiva Rus, Alfonso
dc.contributor.authorObieta, Anaida
dc.contributor.authorPascual, Victoria
dc.contributor.authorPericàs Pulido, Pau
dc.contributor.authorRaduán de Páramo, Carlos
dc.contributor.authorSegura, Elsa
dc.contributor.authorVega, Verónica
dc.contributor.authorBalearic COVID-19 Pediatric Primary Care Research Group
dc.date.accessioned2024-10-09T06:33:54Z
dc.date.available2024-10-09T06:33:54Z
dc.date.issued2023-08-29
dc.description.abstractBackground: Rapid antigen-detection tests (Ag-RDTs) are used to diagnose SARS-CoV-2 infection. Real-world studies of Ag-RDTs are necessary to evaluate their diagnostic yield in paediatric patients. Our aim was to evaluate the accuracy of the Panbio™ Rapid Antigen Test for SARS-CoV-2 in the setting of a primary health care centre (PHC), with use of the Reverse Transcription-Polymerase Chain Reaction (RT-PCR) as gold standard. Methods: This prospective diagnostic study was conducted at PHCs in Mallorca, Spain. Patients were ≤ 18 years-old that attended sites for RT-PCR testing due to symptoms suggestive of infection (fever, headache, nasal congestion and dry cough, among others) or epidemiological exposure (close contacts). Two samples were collected: a nasal mid-turbinate sample for Ag-RDTs and a nasopharyngeal swab for RT-PCR testing. The sensitivity, specificity, and predictive values of the AgRDT were calculated using the RT-PCR results as the reference. Results: We examined 1142 participants from 0 to 18 years (47.5% female, mean age 8.9 ± 4.8 years, median 9.0 [5.0-13.0]). There were 84 positive RT-PCR results (pre-test probability of 7.3%) and 52 positive Ag-RDT results. The sensitivity of the Ag-RDT was 59.5% (95% Confidence Interval (CI): 48.2-69.9%), the specificity was 99.8% (95%CI: 99.2-99.9%), the positive predictive value was 96.1% (95%CI: 85.6-99.4%), and the negative predictive value was 96.8% (95%CI: 95.6-97.7%). The sensitivity for individuals referred by a general practitioner (GP) or paediatrician due to symptoms was 71.4% (95%CI: 51.5-86.0%) and for asymptomatic individuals was 50.0% (95%CI: 9.1-90.8%). The specificity was greater than 98.9% overall and in all subgroups. The sensitivity was 73.0% (95%CI: 52.0-87.5%) for referred patients due to symptoms and who were tested within 5 days since symptom onset. No significant statistical differences between any groups were found. There were 34 false-negative Ag-RDT results (40.5%) and 2 false-positive Ag-RDT results (0.2%). Conclusion: The sensitivity of the Panbio™ Test in paediatric individuals is below the minimum of 80% recommended by the World Health Organization for Ag-RDTs. This test had better accuracy in individuals referred by a GP or paediatrician due to symptoms, rather than those who were asymptomatic or referred due to epidemiological exposure. The RT-PCR test using a nasopharyngeal swab is accurate, but a less invasive alternative that has better sensitivity than the Panbio™ Test is needed for paediatric populations.en
dc.description.sponsorshipThis study was supported by the Balearic Public Health Service and there was no external funding.es_ES
dc.format.number433es_ES
dc.format.volume23es_ES
dc.identifier.citationGallardo-Alfaro L, Lorente-Montalvo P, Cañellas M, Carandell E, Oliver A, Rojo E, et al. Diagnostic accuracy of PanbioTM rapid antigen test for SARS-CoV-2 in paediatric population. BMC Pediatrics. 2023 Aug 29;23(1):433.en
dc.identifier.doi10.1186/s12887-023-04201-z
dc.identifier.issn1471-2431
dc.identifier.journalBMC Pediatricses_ES
dc.identifier.otherhttps://hdl.handle.net/20.500.13003/19328
dc.identifier.pubmedID37644389es_ES
dc.identifier.urihttps://hdl.handle.net/20.500.12105/23632
dc.language.isoengen
dc.publisherBioMed Central (BMC)
dc.relation.publisherversionhttps://doi.org/10.1186/s12887-023-04201-zen
dc.rights.accessRightsopen accessen
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCOVID-19
dc.subjectRapid antigen test
dc.subjectSARS-CoV-2
dc.subjectPrimary care
dc.subjectPaediatric
dc.subject.decsAdolescente*
dc.subject.decsPrueba de COVID-19*
dc.subject.decsCOVID-19*
dc.subject.decsNiño*
dc.subject.decsNiño preescolar*
dc.subject.decsTos*
dc.subject.decsFemenino*
dc.subject.decsFiebrer*
dc.subject.decsSeres humanos*
dc.subject.decsMasculino*
dc.subject.decsEstudios Prospectivos*
dc.subject.decsSARS-CoV-2*
dc.subject.meshAdolescent*
dc.subject.meshCOVID-19 Testing*
dc.subject.meshCOVID-19*
dc.subject.meshChild*
dc.subject.meshChild, Preschool*
dc.subject.meshCough*
dc.subject.meshFemale*
dc.subject.meshFever*
dc.subject.meshHumans*
dc.subject.meshMale*
dc.subject.meshProspective Studies*
dc.subject.meshSARS-CoV-2*
dc.titleDiagnostic accuracy of Panbio™ rapid antigen test for SARS-CoV-2 in paediatric populationen
dc.typeresearch articleen
dspace.entity.typePublication
relation.isPublisherOfPublication4fe896aa-347b-437b-a45b-95f4b60d9fd3
relation.isPublisherOfPublication.latestForDiscovery4fe896aa-347b-437b-a45b-95f4b60d9fd3

Files